National Health Investors (NHI) Rating Lowered to Hold at Zacks Investment Research
National Health Investors (NYSE:NHI) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued on Friday.
According to Zacks, “National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. “
NHI has been the subject of several other research reports. Cantor Fitzgerald upped their price target on shares of National Health Investors from $75.00 to $80.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 8th. Stifel Nicolaus set a $83.00 price target on shares of National Health Investors and gave the stock a “buy” rating in a research report on Tuesday, August 7th. SunTrust Banks restated a “hold” rating and set a $79.00 price target on shares of National Health Investors in a research report on Wednesday, August 8th. They noted that the move was a valuation call. Finally, Wells Fargo & Co restated a “hold” rating on shares of National Health Investors in a research report on Tuesday, August 28th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $75.22.
National Health Investors (NYSE:NHI) last released its earnings results on Tuesday, November 6th. The real estate investment trust reported $0.97 earnings per share for the quarter, missing the consensus estimate of $1.39 by ($0.42). National Health Investors had a net margin of 53.15% and a return on equity of 11.56%. The business had revenue of $74.92 million for the quarter, compared to the consensus estimate of $73.72 million. During the same quarter in the previous year, the firm earned $1.37 EPS. The firm’s revenue for the quarter was up 5.0% on a year-over-year basis. Equities research analysts predict that National Health Investors will post 5.5 earnings per share for the current fiscal year.
A number of hedge funds and other institutional investors have recently modified their holdings of NHI. Truvestments Capital LLC purchased a new stake in National Health Investors during the third quarter valued at about $108,000. First Hawaiian Bank purchased a new stake in National Health Investors during the third quarter valued at about $162,000. Nissay Asset Management Corp Japan ADV purchased a new stake in National Health Investors during the third quarter valued at about $203,000. Zeke Capital Advisors LLC purchased a new stake in National Health Investors during the second quarter valued at about $201,000. Finally, MML Investors Services LLC purchased a new stake in National Health Investors during the third quarter valued at about $212,000. 68.79% of the stock is owned by institutional investors.
About National Health Investors
Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
See Also: Marijuana Stocks
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.